- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Genprex Inc (GNPX)
Genprex Inc stock price live, this page displays NASDAQ GNPX stock exchange data. View the GNPX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Genprex Inc real time stock price chart below.
What Is the Genprex Inc Stock Price Today?
The Genprex Inc stock price today is 0.164.
What Is the Stock Symbol for Genprex Inc?
The stock symbol for Genprex Inc is ""GNPX.""
What Stock Exchange Does Genprex Inc Trade On?
Genprex Inc is listed and trades on the NASDAQ stock exchange.
Is Genprex Inc a Good Stock to Buy?
Determining whether Genprex Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GNPX quote. (ISIN: US3724462037)
What Is the Genprex Inc Stock Price Today?
The Genprex Inc stock price today is 0.164.
What Is the Stock Symbol for Genprex Inc?
The stock symbol for Genprex Inc is ""GNPX.""
What Stock Exchange Does Genprex Inc Trade On?
Genprex Inc is listed and trades on the NASDAQ stock exchange.
Is Genprex Inc a Good Stock to Buy?
Determining whether Genprex Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GNPX quote. (ISIN: US3724462037)
Fair Value
An estimate of a Genprex's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.149
0.180
52 wk Range
0.140
3.970
GNPX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
GNPX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Genprex's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.1490.180
52 wk Range
0.1403.970
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
GNPX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Genprex's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Suffers from weak gross profit margins
- Form 8K Genprex Inc For: 24 June
- Investing.com
- Form 8K Genprex Inc For: 18 August
- Investing.com
- Form 8K Genprex Inc For: 18 August
- Investing.com
- Form 8K Genprex Inc For: 4 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Genprex Inc Company Profile
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. The company’s technologies are designed to administer disease-fighting genes to provide new therapies for patient populations with cancer and diabetes. Its oncology program utilizes its systemic, non-viral Oncoprex Delivery System, which encapsulates the gene-expressing plasmids using lipid-based nanoparticles in a lipoplex form. The company’s lead product candidate, Reqorsa Immunogene Therapy (quaratusugene ozeplasmid), is being evaluated in three clinical trials as a treatment for NSCLC and SCLC. Its three lung cancer clinical programs have received a Fast Track Designation from the FDA for the treatment of that patient population, and SCLC program has received an FDA Orphan Drug Designation. The company’s diabetes gene therapy comprises of a novel infusion process that uses an AAV vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of Type 1 diabetes, its GPX-002 transforms alpha cells in the pancreas into functional beta-like cells, which produce insulin but distinct enough from beta cells to evade the body’s immune system; and GPX-002 for Type 2 diabetes, where autoimmunity is not at play, is believed to rejuvenate and replenish exhausted beta cells. It has research agreement with The University of Michigan Rogel Cancer Center and Lung Cancer Study Collaboration with ALK Positive. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
Compare GNPX to Peers and Sector
Metrics to compare | GNPX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGNPXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −0.3x | −3.0x | −0.5x | |
PEG Ratio | 0.00 | 0.02 | 0.00 | |
Price/Book | 3.9x | 2.2x | 2.6x | |
Price / LTM Sales | - | 132.5x | 3.3x | |
Upside (Analyst Target) | - | 176.2% | 38.9% | |
Fair Value Upside | Unlock | −1.7% | 5.4% | Unlock |
Earnings
Latest Release
Aug 14, 2025
EPS / Forecast
-0.17 / -0.74
Revenue / Forecast
-- / --
People Also Watch
FAQ
What Stock Exchange Does Genprex Trade On?
Genprex is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Genprex?
The stock symbol for Genprex is "GNPX."
What Is the Genprex Market Cap?
As of today, Genprex market cap is 5.49M.
What Is Genprex's Earnings Per Share (TTM)?
The Genprex EPS (TTM) is -1.27.
From a Technical Analysis Perspective, Is GNPX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Genprex Stock Split?
Genprex has split 1 times.
How Many Employees Does Genprex Have?
Genprex has 15 employees.
What is the current trading status of Genprex (GNPX)?
As of 30 Aug 2025, Genprex (GNPX) is trading at a price of 0.164, with a previous close of 0.18. The stock has fluctuated within a day range of 0.149 to 0.180, while its 52-week range spans from 0.140 to 3.970.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.